US Patent 7259136 Compositions and methods for treating peripheral vascular disease
Patent 7259136 was granted and assigned to Amylin Pharmaceuticals on August, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+193 characters)
Article
Patent abstract
The present invention relates to methods of treating intermittent claudication comprising administering glucagon-like peptide-1 (GLP-1) molecules to subjects suffering therefrom.
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07259136 Compositions and methods for treating peripheral vascular disease US Patent 7259136 Compositions and methods for treating peripheral vascular disease
Infobox
Patent Number
0725913600
Patent Number
725913600
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072591360
Date of Patent
August 21, 2007
0Patent Application Number
100912580
Date Filed
March 5, 2002
0Official Website
Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072591360
Date of Patent
August 21, 2007
0Patent Application Number
100912580
Date Filed
March 5, 2002
0Official Website
Patent Primary Examiner
Edits on 16 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 22 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07259136 Compositions and methods for treating peripheral vascular disease
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07259136
Date of patent
August 21, 2007
Patent application number
10091258
Date Filed
March 5, 2002
Patent primary examiner
Find more entities like US Patent 7259136 Compositions and methods for treating peripheral vascular disease
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
